American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Controlling tuberculosis in the United States

American Journal of Respiratory and Critical Care Medicine

Volumn 172, Issue 9, 2005, Pages 1169-1227

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ACID FAST BACTERIUM; ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BCG VACCINATION; BIOTECHNOLOGICAL PROCEDURES; DEMOGRAPHY; DISEASE COURSE; DISEASE TRANSMISSION; DRUG INDUSTRY; EMPLOYMENT; EPIDEMIC; GENETIC SUSCEPTIBILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH EDUCATION; HEALTH INSURANCE; HEALTH PROGRAM; HEALTH SURVEY; HIGH RISK POPULATION; HOSPITAL SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INCIDENCE; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; LUNG TUBERCULOSIS; MASS SCREENING; MEDICAL CARE; MEDICAL PRACTICE; MEDICAL SCHOOL; MEDICAL SERVICE; MILIARY TUBERCULOSIS; MORBIDITY; MORTALITY; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; OCCUPATIONAL HAZARD; PATHOGENICITY; PATIENT COMPLIANCE; PATIENT EDUCATION; PREVALENCE; PRIORITY JOURNAL; PRISONER; PUBLIC HEALTH; REVIEW; SKIN TEST; SOCIOECONOMICS; SPUTUM ANALYSIS; SURGEON; THORAX RADIOGRAPHY; TUBERCULOSIS; TUBERCULOUS MENINGITIS; UNITED STATES;

ADOLESCENT; ADULT; CHILD; EMIGRATION AND IMMIGRATION; HEALTH PERSONNEL; HIV INFECTIONS; HOMELESS PERSONS; HUMANS; PRISONERS; PROFESSIONAL ROLE; PUBLIC HEALTH PRACTICE; RISK FACTORS; TUBERCULOSIS; UNITED STATES; UNITED STATES PUBLIC HEALTH SERVICE;

EID: 30344446987     PISSN: 1073449X     EISSN: 1073449X     Source Type: Journal    
DOI: 10.1164/rccm.2508001     Document Type: Review

References (442)

1. Centers for Disease Control and Prevention. Tuberculosis elimination revisited: obstacles, opportunities, and a renewed commitment - Advisory Council for the Elimination of Tuberculosis (ACET). MMWR Morb Mortal Wkly Rep 1999;48(RR-9):1-13.
2. Institute of Medicine. Ending neglect: the elimination of tuberculosis in the United States. Washington, DC: Institute of Medicine, National Academy Press; 2000.
3. American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society of America. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000;161:1376-1395.
4. American Thoracic Society, Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161(Suppl):S221-S247.
5. American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society of America. Treatment of tuberculosis. Am J Respir Crit Care Med 2003;167:603-662.
6. American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society of America. Control of tuberculosis in the United States. Am Rev Respir Dis 1992;146:1623-1633.
7. Kish MA, for the Infectious Diseases Society of America. Guide to development of practice guidelines. Clin Infect Dis 2001;32:851-854.
8. Horsburgh CR Jr, Feldman S, Ridzon R, for the Infectious Diseases Society of America. Practice guidelines for the treatment of tuberculosis. Clin Infect Dis 2000;31:633-639.
9. Centers for Disease Control and Prevention. Guidelines for preventing opportunistic infections among HIV-infected persons - 2002: recommendations of the US Public Health Service and the Infectious Diseases Society of America. MMWR Morb Mortal Wkly Rep 2002;51(RR-8):1-52.
10. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. MMWR Morb Mortal Wkly Rep 1994;43(RR-13):1-132.
11. Centers for Disease Control and Prevention. A strategic plan for the elimination of tuberculosis in the United States. MMWRMorb Mortal Wkly Rep 1989;38:269-272.
12. National Coalition for the Elimination of Tuberculosis. Tuberculosis elimination: the federal funding gap. Washington, DC: National Coalition for the Elimination of Tuberculosis; 2002.
13. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City: turning the tide. N Engl J Med 1995;333:229-233.
14. Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2003. Atlanta, GA; U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2004.
15. Centers for Disease Control and Prevention. Trends in tuberculosis: United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2004;53:209-214.
16. McKenna MT, McCray E, Jones JL, Onorato IM, Castro KG. The fall after the rise: tuberculosis in the United States, 1991 through 1994. Am J Public Health 1998;88:1059-1063.
17. Centers for Disease Control and Prevention. Essential components of a tuberculosis prevention and control program: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep 1995;44(RR-11):1-16.
18. Rubel AJ, Garro LC. Social and cultural factors in the successful control of tuberculosis. Public Health Rep 1992;107:626-636.
19. Asch S, Leake B, Gelberg L. Does fear of immigration authorities deter tuberculosis patients from seeking care? West J Med 1994;161:373-376.
20. Sherman LF, Fujiwara PI, Cook SV, Bazerman LB, Frieden TR. Patient and health care system delays in the diagnosis and treatment of tuberculosis. Int J Tuberc Lung Dis 1999;3:1088-1095.
21. Talbot EA, Moore M, McCray E, Binkin NJ. Tuberculosis among foreign-born persons in the United States, 1993-1998. JAMA 2000;284:2894-2900.
22. DeRiemer K, Rudoy I, Schecter GF, Hopewell PC, Daley CL. The epidemiology of tuberculosis diagnosed after death in San Francisco, 1986-1995. Int J Tuberc Lung Dis 1999;3:488-493.
23. Kramer F, Modilevsky T, Waliany AR, Leedom JM,Barnes PF. Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Am J Med 1990;89:451-456.
24. Rao VK, Iademarco EP, Fraser VJ, Kollef MH. Delays in the suspicion and treatment of tuberculosis among hospitalized patients. Ann Intern Med 1999;130:404-411.
25. Curtis AB, Ridzon R, Vogel R, et al. Extensive transmission of Mycobacterium tuberculosis from a child. N Engl J Med 1999;341:1491-1495.
26. Fitzpatrick LK, Hardacker JA, Heirendt W, et al. A preventable outbreak of tuberculosis investigated through an intricate social network. Clin Infect Dis 2001;33:1801-1806.
27. Weis SE, Pogoda JM,Yang Z, et al. Transmission dynamics of tuberculosis in Tarrant County, Texas. Am J Respir Crit Care Med 2002;166:36-42.
28. Bishai WR, Graham NM, Harrington S, et al. Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy. JAMA 1998;280:1679-1684.
29. Chin DP, Crane CM, Diul MY, et al. Spread of Mycobacterium tuberculosis in a community implementing recommended elements of tuberculosis control. JAMA 2000;283:2968-2974.
30. Reichler MR, Reves R, Bur S, et al. Evaluation of investigations conducted to detect and prevent transmission of tuberculosis. JAMA 2002;287:991-995.
31. Marks SM, Taylor Z, Qualls NL, Shrestha-Kuwahara RJ, Wilce MA, Nguyen CH. Outcomes of contact investigations of infectious tuberculosis patients. Am J Respir Crit Care Med 2000;162:2033-2038.
32. Reichler MR, Reves R, Bur S, et al., for the Contact Investigation Study Group. Treatment of latent tuberculosis infection in contacts of new tuberculosis cases in the United States. South Med J 2002;95:414-420.
33. Barnes PF, Yang Z, Pogoda JM, et al. Foci of tuberculosis transmission in central Los Angeles. Am J Respir Crit Care Med 1999;159:1081-1086.
34. Sterling TR, Thompson D, Stanley RL, et al. A multi-state outbreak of tuberculosis among members of a highly mobile social network: implications for tuberculosis elimination. Int J Tuberc Lung Dis 2000;4:1066-1073.
35. Centers for Disease Control and Prevention. Drug-susceptible tuberculosis outbreak in a state correctional facility housing HIV-infected inmates: South Carolina, 1999-2000. MMWR Morb Mortal Wkly Rep 2000;49:1041-1044.
36. Conover C, Ridzon R, Valway S, et al. Outbreak of multidrug-resistant tuberculosis at a methadone treatment program. Int J Tuberc Lung Dis 2001;5:59-64.
37. McLaughlin SI, Spradling P, Drociuk D, Ridzon R, Pozsik CJ, Onorato I. Extensive transmission of Mycobacterium tuberculosis among congregated, HIV-infected prison inmates in South Carolina, United States. Int J Tuberc Lung Dis 2003;7:665-672.
38. Centers for Disease Control and Prevention. Cluster of tuberculosis cases among exotic dancers and their close contacts: Kansas, 1994-2000. MMWR Morb Mortal Wkly Rep 2001;50:291-293.
39. Bennett DE, Courval JM, Onorato IM, et al. Prevalence of TB infection in the US population, 1999-2000 [abstract 67921]. In: Program and abstracts, 131st annual meeting of the American Public Health Association, San Francisco, California, November 15-19, 2003.
40. Chaulk CP, Grady M. Evaluating tuberculosis control programs: strategies, tools and models. Int J Tuberc Lung Dis 2000;4(2, Suppl 1)S55-S60.
41. Nardell EA. Needles in haystacks: diagnosing tuberculosis under low prevalence conditions. Tuber Lung Dis 1996;77:389-390.
42. Mahmoudi A, Iseman MD. Pitfalls in the care of patients with tuberculosis: common errors and their association with the acquisition of drug resistance. JAMA 1993;270:65-68.
43. Institute of Medicine. The future of public health. Washington, DC: Institute of Medicine, National Academy Press; 1988.
44. Corbett EL,Watt CJ,Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003;163:1009-1021.
45. Miller B, Castro KG. Sharpen available tools for tuberculosis control, but new tools needed for elimination. JAMA 1996;276:1916-1917.
46. Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet 2003;362:887-899.
47. Cantwell MF, Snider DE Jr, Cauthen GM, Onorato IM. Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA 1994;272:535-539.
48. Centers for Disease Control and Prevention. Progressing toward tuberculosis elimination in low-incidence areas of the United States: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep 2002;51(RR-5):1-16.
49. Hopewell PC. Targeting tuberculosis prevention. Am J Respir Crit Care Med 2000;162:2017-2018.
50. Desonia R. Running on empty: the state budget crisis worsens. Nat Health Policy Forum Issue Brief 2002(783):1-19.
51. Nolan CM. Community-wide implementation of targeted testing for and treatment of latent tuberculosis infection. Clin Infect Dis 1999;29:880-887.
52. Fischl MA, Uttamchandani RB, Daikos GL, et al. An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection. Ann Intern Med 1992;117:177-183.
53. Beck-Sague C, Dooley SW, Hutton MD, et al. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections: factors in transmission to staff and HIV-infected patients. JAMA 1992;268:1280-1286.
54. Edlin BR, Tokars JI, Grieco MH, et al. An outbreak of multidrugresistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992;326:1514-1521.
55. Ellis BA, Crawford JT, Braden CR, McNabb SJ, Moore M, Kammerer S, for the National Tuberculosis Genotyping and Surveillance Network Work Group. Molecular epidemiology of tuberculosis in a sentinel surveillance population. Emerg Infect Dis 2002;8:1197-1209.
56. Blumberg HM, Watkins DL, Berschling JD, et al. Preventing the nosocomial transmission of tuberculosis. Ann Intern Med 1995;122:658-663.
57. Grzybowski S, Barnett GD, Styblo K. Contacts of cases of active pulmonary tuberculosis. Bull Int Union Tuberc 1975;50:90-106.
58. Shaw JB, Wynn-Williams N. Infectivity of pulmonary tuberculosis in relation to sputum status. Am Rev Tuberc 1954;69:724-732.
59. van Geuns HA, Meijer J, Styblo K. Results of contact examination in Rotterdam, 1967-1969. Bull Int Union Tuberc 1975;50:107-121.
60. Bailey WC, Gerald LB,Kimerling ME, et al. Predictive model to identify positive tuberculosis skin test results during contact investigations. JAMA 2002;287:996-1002.
61. Behr MA, Warren SA, Salamon H, et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 1999;353:444-449.
62. Stead WW, Lofgren JP, Warren E, Thomas C. Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. N Engl J Med 1985;312:1483-1487.
63. Stead WW, To T. The significance of the tuberculin skin test in elderly persons. Ann Intern Med 1987;107:837-842.
64. Small PM, Shafer RW, Hopewell PC, et al. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med 1993;328:1137-1144.
65. Godfrey-Faussett P, Sonnenberg P, Shearer SC, et al. Tuberculosis control and molecular epidemiology in a South African gold-mining community. Lancet 2000;356:1066-1071.
66. Colditz GA, Brewer TF, Berkey CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA 1994;271:698-702.
67. Fine PE. BCG: the challenge continues. Scand J Infect Dis 2001;33:243-245.
68. Styblo K, Meijer J. Impact of BCG vaccination programmes in children and young adults on the tuberculosis problem. Tubercle 1976;57:17-43.
69. Aronson NE, Santosham M, Comstock GW, et al. Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study. JAMA 2004;291:2086-2091.
70. Sterne JA, Rodrigues LC, Guedes IN. Does the efficacy of BCG decline with time since vaccination? Int J Tuberc Lung Dis 1998;2:200-207.
71. Flynn JL, Chan J. Tuberculosis: latency and reactivation. Infect Immun 2001;69:4195-4201.
72. Schluger NW. Recent advances in our understanding of human host responses to tuberculosis. Respir Res 2001;2:157-163.
73. Stead WW. Genetics and resistance to tuberculosis: could resistance be enhanced by genetic engineering? Ann Intern Med 1992;116:937-941.
74. Sousa AO, Salem JI, Lee FK, et al. An epidemic of tuberculosis with a high rate of tuberculin anergy among a population previously unexposed to tuberculosis, the Yanomami Indians of the Brazilian Amazon. Proc Natl Acad Sci USA 1997;94:13227-13232.
75. Boom WH, Canaday DH, Fulton SA, Gehring AJ, Rojas RE, Torres M. Human immunity to M. tuberculosis: T cell subsets and antigen processing. Tuberculosis (Edinb) 2003;83:98-106.
76. Nardell EA, Keegan J, Cheney SA, Etkind SC. Airborne infection: theoretical limits of protection achievable by building ventilation. Am Rev Respir Dis 1991;144:302-306.
77. Rieder HL. Risk of travel-associated tuberculosis. Clin Infect Dis 2001;33:1393-1396.
78. Houk VN, Baker JH, Sorensen K, Kent DC. The epidemiology of tuberculosis infection in a closed environment. Arch Environ Health 1968;16:26-35.
79. Houk VH, Kent DC, Baker JH, Sorensen K, Hanzel GD. The Byrd study: in-depth analysis of amicro-outbreak of tuberculosis in a closed environment. Arch Environ Health 1968;16:4-6.
80. Suzuki S, Nakabayashi K, Ohkouchi H, et al. Tuberculosis in the crew of a submarine [in Japanese]. Nihon Kyobu Shikkan Gakkai Zasshi 1997;35:61-66.
81. World Health Organization. Tuberculosis and air travel: guidelines for prevention and control. Geneva, Switzerland: World Health Organization; 1998.
82. Centers for Disease Control and Prevention. Exposure of passengers and flight crew to Mycobacterium tuberculosis on commercial aircraft, 1992-1995. MMWR Morb Mortal Wkly Rep 1995;44:137-140.
83. Kato-Maeda M, Bifani PJ, Kreiswirth BN, Small PM. The nature and consequence of genetic variability within Mycobacterium tuberculosis. J Clin Invest 2001;107:533-537.
84. Barnes PF, Cave MD. Molecular epidemiology of tuberculosis. N Engl J Med 2003;349:1149-1156.
85. Bifani PJ, Mathema B, Liu Z, et al. Identification of aWvariant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology. JAMA 1999;282:2321-2327.
86. Munsiff SS, Nivin B, Sacajiu G, Mathema B, Bifani P, Kreiswirth BN. Persistence of a highly resistant strain of tuberculosis in New York City during 1990-1999. J Infect Dis 2003;188:356-363.
87. Zhang M, Gong J, Yang Z, Samten B, Cave MD, Barnes PF. Enhanced capacity of a widespread strain of Mycobacterium tuberculosis to grow in human macrophages. J Infect Dis 1999;179:1213-1217.
88. Middlebrook G, Cohn ML. Some observations on the pathogenicity of isoniazid-resistant variants of tubercle bacilli. Science 1953;118:297-299.
89. Burgos M, DeRiemer K, Small PM, Hopewell PC, Daley CL. Effect of drug resistance on the generation of secondary cases of tuberculosis. J Infect Dis 2003;188:1878-1884.
90. van Soolingen D, Borgdorff MW, de Haas PE, et al. Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997. J Infect Dis 1999;180:726-736.
91. Snider DE Jr, Kelly GD, Cauthen GM, Thompson NJ, Kilburn JO. Infection and disease among contacts of tuberculosis cases with drugresistant and drug-susceptible bacilli. Am Rev Respir Dis 1985;132:125-132.
92. Frieden TR, Sherman LF, Maw KL, et al. A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. JAMA 1996;276:1229-1235.
93. Kamat SR, Dawson JJ, Devadatta S, et al. A controlled study of the influence of segregation of tuberculous patients for one year on the attack rate of tuberculosis in a 5-year period in close family contacts in South India. Bull World Health Organ 1966;34:517-532.
94. Gunnels JJ, Bates JH, Swindoll H. Infectivity of sputum-positive tuberculous patients on chemotherapy. Am Rev Respir Dis 1974;109:323-330.
95. Brindle R, Odhiambo J, Mitchison D. Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosis. BMC Pulm Med 2001;1:2.
96. Loudon RG, Spohn SK. Cough frequency and infectivity in patients with pulmonary tuberculosis. Am Rev Respir Dis 1969;99:109-111.
97. Goodwin RA Jr. Pulmonary tuberculosis. In: Wyngaarden JB, Smith LH Jr., editors. Cecil textbook of medicine. Vol. 2, 16th ed. Philadelphia: W.B. Saunders; 1982. pp. 1542-1548.
98. Hopewell PC.Mycobacterial diseases. In: Murray JF, Nadel JA, editors. Textbook of respiratory medicine. Philadelphia: W.B. Saunders; 1988. pp. 856-915.
99. Jindani A, Aber VR, Edwards EA, Mitchison DA. The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am Rev Respir Dis 1980;121:939-949.
100. Jindani A, Dore CJ,Mitchison DA. Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days. Am J Respir Crit Care Med 2003;167:1348-1354.
101. Earnest MA, Sbarbaro JA. Defining the issues: returning patients with tuberculosis to institutional settings. Clin Infect Dis 1995;20:497-500.
102. Mazurek GH, LoBue PA, Daley CL, et al. Comparison of a wholeblood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 2001;286:1740-1747.
103. Centers for Diease Control and Prevention. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. MMWRMorb Mortal Wkly Rep 2003;52(RR-2):15-18.
104. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis: a general review. Bibl Tuberc 1970;26:28-106.
105. Boucot KR, Dillon ES, Cooper DA, Meier P, Richardson R. Tuberculosis among diabetics: the Philadelphia survey. Am Rev Tuberc 1952;65:1-50.
106. International Union against Tuberculosis Committee of Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull World Health Organ 1982;60:555-564.
107. Gardam MA, Keystone EC, Menzies R, et al. Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 2003;3:148-155.
108. Ellerin T, Rubin RH, Weinblatt ME. Infections and anti-tumor necrosis factor alpha therapy. Arthritis Rheum 2003;48:3013-3022.
109. Centers for Diease Control and Prevention. Tuberculosis associated with blocking agents against tumor necrosis factor-alpha: California, 2002-2003. MMWR Morb Mortal Wkly Rep 2004;53:683-686.
110. Centers for Diease Control and Prevention. Case definitions for infectious conditions under public health surveillance.MMWRMorb Mortal Wkly Rep 1997;46(RR-10):1-55.
111. Centers for Diease Control and Prevention. Surveillance appendix I. Tuberculosis Information Management System (TIMS) user's guide, version 1.10. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Diease Control and Prevention; 2001.
112. Cantwell MF, McKenna MT, McCray E, Onorato IM. Tuberculosis and race/ethnicity in the United States: impact of socioeconomic status. Am J Respir Crit Care Med 1998;157:1016-1020.
113. McKenna MT, Hutton M, Cauthen G, Onorato IM. The association between occupation and tuberculosis: a population-based survey. Am J Respir Crit Care Med 1996;154:587-593.
114. Panlilio AL, Burwen DR, Curtis AB, et al. Tuberculin skin testing surveillance of health care personnel. Clin Infect Dis 2002;35:219-227.
115. Zuber PL, McKenna MT, Binkin NJ, Onorato IM, Castro KG. Long-term risk of tuberculosis among foreign-born persons in the United States. JAMA 1997;278:304-307.
116. McKenna MT, McCray E, Onorato I. The epidemiology of tuberculosis among foreign-born persons in the United States, 1986 to 1993. N Engl J Med 1995;332:1071-1076.
117. Burt MR, Aron LY, Douglas T, Valente J, Lee E, Iwen B, for the Urban Institute. Homelessness: programs and the people they serve: findings of the National Survey of Homeless Assistance Providers and Clients. Washington, DC: U.S. Department of Housing and Urban Development; 1999. Available from: http://www.huduser.org/publications/homeless/homeless_tech.html.
118. Moss AR, Hahn JA, Tulsky JP, Daley CL, Small PM, Hopewell PC. Tuberculosis in the homeless: a prospective study. Am J Respir Crit Care Med 2000;162:460-464.
119. Barnes PF, el-Hajj H, Preston-Martin S, et al. Transmission of tuberculosis among the urban homeless. JAMA 1996;275:305-307.
120. Curtis AB, Ridzon R, Novick LF, et al. Analysis of Mycobacterium tuberculosis transmission patterns in a homeless shelter outbreak. Int J Tuberc Lung Dis 2000;4:308-313.
121. Zolopa AR, Hahn JA, Gorter R, et al. HIV and tuberculosis infection in San Francisco's homeless adults: prevalence and risk factors in a representative sample. JAMA 1994;272:455-461.
122. Selwyn PA, Sckell BM, Alcabes P, Friedland GH, Klein RS, Schoenbaum EE. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA 1992;268:504-509.
123. Centers for Diease Control and Prevention. Prevention and control of tuberculosis in correctional facilities: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep 1996;45(RR-8):1-27.
124. Glaser JB, Greifinger RB. Correctional health care: a public health opportunity. Ann Intern Med 1993;118:139-145.
125. U.S. Department of Justice. Profile of jail inmates, 1996. Washington, DC: U.S. Department of Justice, Bureau of Justice Statistics; 1998.
126. Centers for Diease Control and Prevention. Tuberculosis outbreaks in prison housing units for HIV-infected inmates: California, 1995-1996. MMWR Morb Mortal Wkly Rep 1999;48:79-82.
127. Jones TF, Craig AS, Valway SE, Woodley CL, Schaffner W. Transmission of tuberculosis in a jail. Ann Intern Med 1999;131:557-563.
128. Jones TF, Woodley CL, Fountain FF, Schaffner W. Increased incidence of the outbreak strain of Mycobacterium tuberculosis in the surrounding community after an outbreak in a jail. South Med J 2003;96:155-157.
129. Cave MD, Eisenach KD, McDermott PF, Bates JH, Crawford JT. IS6110: conservation of sequence in the Mycobacterium tuberculosis complex and its utilization in DNA fingerprinting. Mol Cell Probes 1991;5:73-80.
130. Etkind SC, Veen J. Contact follow-up in high- and low-prevalence countries. In: Reichman LB, Hershfield ES, editors. Tuberculosis: a comprehensive international approach, 2nd ed. NewYork, NewYork: Marcel Dekker; 2000. pp. 275-289.
131. Small PM, Hopewell PC, Singh SP, et al. The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods. N Engl J Med 1994;330:1703-1709.
132. Pfyffer GE, Strassle A, Rose N, Wirth R, Brandli O, Shang H. Transmission of tuberculosis in the metropolitan area of Zurich: a 3 year survey based on DNA fingerprinting. Eur Respir J 1998;11:804-808.
133. van Deutekom H, Gerritsen JJ, van Soolingen D, van Ameijden EJ, van Embden JD, Coutinho RA.Amolecular epidemiological approach to studying the transmission of tuberculosis in Amsterdam. Clin Infect Dis 1997;25:1071-1077.
134. Yaganehdoost A, Graviss EA, Ross MW, et al. Complex transmission dynamics of clonally related virulent Mycobacterium tuberculosis associated with barhopping by predominantly human immunodeficiency virus-positive gay men. J Infect Dis 1999;180:1245-1251.
135. Tabet SR, Goldbaum GM, Hooton TM, Eisenach KD, Cave MD, Nolan CM. Restriction fragment length polymorphism analysis detecting a community-based tuberculosis outbreak among persons infected with human immunodeficiency virus. J Infect Dis 1994;169:189-192.
136. Daley CL, Small PM, Schecter GF, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus: an analysis using restriction-fragment-length polymorphisms. N Engl J Med 1992;326:231-235.
137. Leonhardt KK, Gentile F, Gilbert BP, Aiken M. A cluster of tuberculosis among crack house contacts in San Mateo County, California. Am J Public Health 1994;84:1834-1836.
138. March F, Coll P, Guerrero RA, Busquets E, Cayla JA, Prats G. Predictors of tuberculosis transmission in prisons: an analysis using conventional and molecular methods. AIDS 2000;14:525-535.
139. Mohle-Boetani JC, Miguelino V, Dewsnup DH, et al. Tuberculosis outbreak in a housing unit for human immunodeficiency virus-infected patients in a correctional facility: transmission risk factors and effective outbreak control. Clin Infect Dis 2002;34:668-676.
140. Mangura BT, Napolitano EC, Passannante MR, McDonald RJ, Reichman LB. Mycobacterium tuberculosis miniepidemic in a church gospel choir. Chest 1998;113:234-237.
141. Jereb JA, Burwen DR, Dooley SW, et al. Nosocomial outbreak of tuberculosis in a renal transplant unit: application of a new technique for restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates. J Infect Dis 1993;168:1219-1224.
142. Johnson KR, Braden CR, Cairns KL, et al. Transmission of Mycobacterium tuberculosis from medical waste. JAMA 2000;284:1683-1688.
143. Agerton T, Valway S, Gore B, et al. Transmission of a highly drug-resistant strain (strain W1) of Mycobacterium tuberculosis: community outbreak and nosocomial transmission via a contaminated bronchoscope. JAMA 1997;278:1073-1077.
144. Michele TM, Cronin WA, Graham NM, et al. Transmission of Mycobacterium tuberculosis by a fiberoptic bronchoscope: identification by DNA fingerprinting. JAMA 1997;278:1093-1095.
145. Small PM, Fujiwara PI. Management of tuberculosis in the United States. N Engl J Med 2001;345:189-200.
146. Genewein A, Telenti A, Bernasconi C, et al. Molecular approach to identifying route of transmission of tuberculosis in the community. Lancet 1993;342:841-844.
147. Hernandez-Garduno E, Kunimoto D, Wang L, et al. Predictors of clustering of tuberculosis in Greater Vancouver: a molecular epidemiologic study. CMAJ 2002;167:349-352.
148. Barnes PF, Yang Z, Preston-Martin S, et al. Patterns of tuberculosis transmission in Central Los Angeles. JAMA 1997;278:1159-1163.
149. Alland D, Kalkut GE, Moss AR, et al. Transmission of tuberculosis in New York City: an analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994;330:1710-1716.
150. Chin DP, DeRiemer K, Small PM, et al. Differences in contributing factors to tuberculosis incidence in US-born and foreign-born persons. Am J Respir Crit Care Med 1998;158:1797-1803.
151. Jasmer RM, Hahn JA, Small PM, et al. A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991-1997. Ann Intern Med 1999;130:971-978.
152. Geng E, Kreiswirth B, Driver C, et al. Changes in the transmission of tuberculosis in New York City from 1990 to 1999. N Engl J Med 2002;346:1453-1458.
153. Bandera A, Gori A, Catozzi L, et al. Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis. J Clin Microbiol 2001;39:2213-2218.
154. van Rie A, Warren R, Richardson M, et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med 1999;341:1174-1179.
155. Maurer JR, Desmond EP, Lesser MD, Jones WD Jr. False-positive cultures of Mycobacterium tuberculosis. Chest 1984;86:439-443.
156. Burman WJ,Reves RR. Review of false-positive cultures for Mycobacterium tuberculosis and recommendations for avoiding unnecessary treatment. Clin Infect Dis 2000;31:1390-1395.
157. Bruchfeld J, Aderaye G, Palme IB, Bjorvatn B, Kallenius G, Lindquist L. Sputum concentration improves diagnosis of tuberculosis in a setting with a high prevalence of HIV. Trans R Soc Trop Med Hyg 2000;94:677-680.
158. Small PM, McClenny NB, Singh SP, Schoolnik GK, Tompkins LS, Mickelsen PA.Molecular strain typing of Mycobacterium tuberculosis to confirm cross-contamination in the mycobacteriology laboratory and modification of procedures to minimize occurrence of false-positive cultures. J Clin Microbiol 1993;31:1677-1682.
159. Burman WJ, Stone BL, Reves RR, et al. The incidence of false-positive cultures for Mycobacterium tuberculosis. Am J Respir Crit Care Med 1997;155:321-326.
160. Jasmer RM, Roemer M, Hamilton J, et al. A prospective, multicenter study of laboratory cross-contamination of Mycobacterium tuberculosis cultures. Emerg Infect Dis 2002;8:1260-1263.
161. CDC. New CDC program for rapid genotyping of Mycobacterium tuberculosis isolates. MMWR Morb Mortal Wkly Rep 2005;54:47.
162. National Tuberculosis Controllers Association, CDC Advisory Group on Tuberculosis Genotyping. Guide to the application of genotyping to tuberculosis prevention and control. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Diease Control and Prevention; 2004.
163. Northrup JM, Miller AC, Nardell E, et al. Estimated costs of false laboratory diagnoses of tuberculosis in three patients. Emerg Infect Dis 2002;8:1264-1270.
164. McNabb SJ, Braden CR, Navin TR. DNA fingerprinting of Mycobacterium tuberculosis: lessons learned and implications for the future. Emerg Infect Dis 2002;8:1314-1319.
165. Kimerling ME, Benjamin WH, Lok KH, Curtis G, Dunlap NE. Restriction fragment length polymorphism screening of Mycobacterium tuberculosis isolates: population surveillance for targeting disease transmission in a community. Int J Tuberc Lung Dis 1998;2:655-662.
166. Dobbs KG, Lok KH, Bruce F, Mulcahy D, Benjamin WH, Dunlap NE. Value of Mycobacterium tuberculosis fingerprinting as a tool in a rural state surveillance program. Chest 2001;120:1877-1882.
167. Kong PM, Tapy J, Calixto P, et al. Skin-test screening and tuberculosis transmission among the homeless. Emerg Infect Dis 2002;8:1280-1284.
168. Miller AC, Sharnprapai S, Suruki R, et al. Impact of genotyping of Mycobacterium tuberculosis on public health practice in Massachusetts. Emerg Infect Dis 2002;8:1285-1289.
169. Etkind SC. The role of the public health department in tuberculosis. Med Clin North Am 1993;77:1303-1314.
170. Dooley SW, Villarino ME, Lawrence M, et al. Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients. JAMA 1992;267:2632-2634.
171. Cowan LS, Crawford JT. Genotype analysis of Mycobacterium tuberculosis isolates from a sentinel surveillance population. Emerg Infect Dis 2002;8:1294-1302.
172. Bock NN, Mallory JP, Mobley N, DeVoe B, Taylor BB. Outbreak of tuberculosis associated with a floating card game in the rural south: lessons for tuberculosis contact investigations. Clin Infect Dis 1998;27:1221-1226.
173. Washko R, Robinson E, Fehrs LJ, Frieden TR. Tuberculosis transmission in a high school choir. J Sch Health 1998;68:256-259.
174. Comstock GW, Woolpert SF, Livesay VT. Tuberculosis studies in Muscogee County, Georgia: twenty-year evaluation of a community trial of BCG vaccination. Public Health Rep 1976;91:276-280.
175. Comstock GW, Livesay VT, Woolpert SF. Evaluation of BCG vaccination among Puerto Rican children. Am J Public Health 1974;64:283-291.
176. Menzies D. What does tuberculin reactivity after bacille Calmette-Guerin vaccination tell us? Clin Infect Dis 2000;31:S71-S74.
177. Ridzon R, Kent JH, Valway S, et al. Outbreak of drug-resistant tuberculosis with second-generation transmission in a high school in California. J Pediatr 1997;131:863-868.
178. Greenaway C, Menzies D, Fanning A, Grewal R, Yuan L, FitzGerald JM, for the Canadian Collaborative Group in Nosocomial Transmission of Tuberculosis. Delay in diagnosis among hospitalized patients with active tuberculosis: predictors and outcomes. Am J Respir Crit Care Med 2002;165:927-933.
179. Centers for Diease Control and Prevention. The role of BCG vaccine in the prevention and control of tuberculosis in the United States: a joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 1996;45(RR-4):1-18.
180. Centers for Diease Control and Prevention. Development of new vaccines for tuberculosis: recommendations of the Advisory Council for the Elimination of Tuberculosis (ACET).MMWRMorb Mortal Wkly Rep 1998;47(RR-13):1-6.
181. Peterson Tulsky J, Castle White M, Young JA, Meakin R, Moss AR. Street talk: knowledge and attitudes about tuberculosis and tuberculosis control among homeless adults. Int J Tuberc Lung Dis 1999;3:528-533.
182. Liefooghe R, Michiels N, Habib S, Moran MB, De Muynck A. Perception and social consequences of tuberculosis: a focus group study of tuberculosis patients in Sialkot, Pakistan. Soc Sci Med 1995;41:1685-1692.
183. Nair DM, George A, Chacko KT. Tuberculosis in Bombay: new insights from poor urban patients. Health Policy Plan 1997;12:77-85.
184. Bock NN, Metzger BS, Tapia JR, Blumberg HM.Atuberculin screening and isoniazid preventive therapy program in an inner-city population. Am J Respir Crit Care Med 1999;159:295-300.
185. Schluger NW, Huberman R, Holzman R, Rom WN, Cohen DI. Screening for infection and disease as a tuberculosis control measure among indigents in New York City, 1994-1997. Int J Tuberc Lung Dis 1999;3:281-286.
186. Shrestha-Kuwahara R, Wilce M, DeLuca N, Taylor Z. Factors associated with identifying tuberculosis contacts. Int J Tuberc Lung Dis 2003;7(12, Suppl 3)S510-S516.
187. Rodger A, Jaffar S, Paynter S, Hayward A, Carless J, Maguire H. Delay in the diagnosis of pulmonary tuberculosis, London, 1998-2000: analysis of surveillance data. BMJ 2003;326:909-910.
188. Allos BM, Genshelmer KF,Bloch AB, et al. Management of an outbreak of tuberculosis in a small community. Ann Intern Med 1996;125:114-117.
189. Kanaya AM, Glidden DV, Chambers HF. Identifying pulmonary tuberculosis in patients with negative sputum smear results. Chest 2001;120:349-355.
190. Curtis AB, McCray E, McKenna M, Onorato IM. Completeness and timeliness of tuberculosis case reporting: a multistate study. Am J Prev Med 2001;20:108-112.
191. Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GM, Dooley SW. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993;328:521-526.
192. Weis SE, Slocum PC, Blais FX, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994;330:1179-1184.
193. Mitchison DA. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc Lung Dis 1998;2:10-15.
194. Sumartojo E. When tuberculosis treatment fails: a social behavioral account of patient adherence. Am Rev Respir Dis 1993;147:1311-1320.
195. Chaulk CP, Moore-Rice K, Rizzo R, Chaisson RE. Eleven years of community-based directly observed therapy for tuberculosis. JAMA 1995;274:945-951.
196. Chaulk CP, Kazandjian VA. Directly observed therapy for treatment completion of pulmonary tuberculosis: consensus statement of the Public Health Tuberculosis Guidelines Panel. JAMA 1998;279:943-948.
197. Bloch AB, Snider DE Jr. How much tuberculosis in children must we accept? Am J Public Health 1986;76:14-15.
198. Lobato MN, Mohle-Boetani JC, Royce SE. Missed opportunities for preventing tuberculosis among children younger than five years of age. Pediatrics 2000;106:E75.
199. DeRiemer K, Daley CL, Reingold AL. Preventing tuberculosis among HIV-infected persons: a survey of physicians' knowledge and practices. Prev Med 1999;28:437-444.
200. Bloom BR, Murray CJ. Tuberculosis: commentary on a reemergent killer. Science 1992;257:1055-1064.
201. Snider DE Jr, Roper WL. The new tuberculosis. N Engl J Med 1992;326:703-705.
202. Hovell MF, Sipan CL, Blumberg EJ, et al. Increasing Latino adolescents' adherence to treatment for latent tuberculosis infection: a controlled trial. Am J Public Health 2003;93:1871-1877.
203. Houston HR, Harada N, Makinodan T. Development of a culturally sensitive educational intervention program to reduce the high incidence of tuberculosis among foreign-born Vietnamese. Ethn Health 2002;7:255-265.
204. Morisky DE, Malotte CK, Ebin V, et al. Behavioral interventions for the control of tuberculosis among adolescents. Public Health Rep 2001;116:568-574.
205. Tokars JI, Rudnick JR, Kroc K, et al. US hospital mycobacteriology laboratories: status and comparison with state public health department laboratories. J Clin Microbiol 1996;34:680-685.
206. Peterson LR, Hamilton JD, Baron EJ, et al. Role of clinical microbiology laboratories in the management and control of infectious diseases and the delivery of health care. Clin Infect Dis 2001;32:605-611.
207. Association of Public Health Laboratories. The future of TB laboratory services: a framework for integration, collaboration and leadership. Washington, DC: Association of Public Health Laboratories; 2004.
208. Centers for Diease Control and Prevention. Core functions and capabilities of state public health laboratories: a report of the Association of Public Health Laboratories. MMWR Morb Mortal Wkly Rep 2002;51(RR-14):1-8.
209. Infectious Diseases Society of America. Policy statement on consolidation of clinical microbiology laboratories. Clin Infect Dis 2001;32:604.
210. Pascopella L, Kellam S, Ridderhof J, et al. Laboratory reporting of tuberculosis test results and patient treatment initiation in California. J Clin Microbiol 2004;42:4209-4213.
211. National Committee for Clinical Laboratory Standards. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard [Document No. M24-A]. Wayne, PA: NCCLS;2003.
212. Reichman LB. How to ensure the continued resurgence of tuberculosis. Lancet 1996;347:175-177.
213. The American Lung Association Conference on re-establishing control of tuberculosis in the United States, Washington, DC, March 11-13, 1994. Am J Respir Crit Care Med 1996;154:251-262.
214. Hopewell PC. The baby and the bath water: the case for retaining categorical services for tuberculosis control in a reformed health care system. Am J Respir Crit Care Med 1994;150:895.
215. Handler A, Issel M, Turnock B. A conceptual framework to measure performance of the public health system. Am J Public Health 2001;91:1235-1239.
216. Binkin NJ, Vernon AA, Simone PM, et al. Tuberculosis prevention and control activities in the United States: an overview of the organization of tuberculosis services. Int J Tuberc Lung Dis 1999;3:663-674.
217. Centers for Diease Control and Prevention. HIPAA privacy rule and public health: guidance from CDC and the US Department of Health and Human Services. MMWR Morb Mortal Wkly Rep 2003;52:1-20.
218. Centers for Diease Control and Prevention. Tuberculosis control laws - United States, 1993: recommendations of the Advisory Council for the Elimination of Tuberculosis (ACET).MMWRMorb Mortal Wkly Rep 1993;42(RR-15):1-28.
219. Hale YM, Pfyffer GE, Salfinger M. Laboratory diagnosis of mycobacterial infections: new tools and lessons learned. Clin Infect Dis 2001;33:834-846.
220. Gostin LO, Burris S, Lazzarini Z. The law and the public's health: a study of infectious disease law in the United States. Columbia Law Rev 1999;99:59-128.
221. Goldberg SV, Wallace J, Jackson JC, Chaulk CP, Nolan CM. Cultural case management of latent tuberculosis infection. Int J Tuberc Lung Dis 2004;8:76-82.
222. Gebbie KM. The public health workforce: key to public health infrastructure. Am J Public Health 1999;89:660-661.
223. Brown CK, Roddy C, for the Joint Council of State and Local Health Officials. Joint Council of State and Local Health Officials: workforce development-principles for action. J Public Health Manag Pract 2001;7:55-59.
224. Jha AK, Perlin JB, Kizer KW, Dudley RA. Effect of the transformation of the Veterans Affairs Health Care System on the quality of care. N Engl J Med 2003;348:2218-2227.
225. Bates DW, Gawande AA. Improving safety with information technology. N Engl J Med 2003;348:2526-2534.
226. Centers for Diease Control and Prevention. Framework for program evaluation in public health. MMWR Morb Mortal Wkly Rep 1999;48(RR-11):1-40.
227. Centers for Diease Control and Prevention. Final FY 2005 performance plan. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Diease Control and Prevention; 2004. Available from: http://www.cdc.gov/od/ perfplan/index.htm.
228. Francis J. Curry National Tuberculosis Center. Quality improvement for TB case management: an online course. San Francisco, CA: Francis J. Curry National Tuberculosis Center; 2004. Available from: http:// ww.nationaltbcenter.edu/ catalogue/online_courses.cfm.
229. Berroa J. Case management: a nursing point of view. Int J Tuberc Lung Dis 1998; 2(9, Suppl 1)S53-S56.
230. Taylor Z, Marks SM, Rios Burrows NM, Weis SE, Stricof RL, Miller B. Causes and costs of hospitalization of tuberculosis patients in the United States. Int J Tuberc Lung Dis 2000;4:931-939.
231. Liu Z, Shilkret KL, Finelli L. Initial drug regimens for the treatment of tuberculosis: evaluation of physician prescribing practices in New Jersey, 1994 to 1995. Chest 1998;113:1446-1451.
232. Asch S, Leake B, Knowles L, Gelberg L. Tuberculosis in homeless patients: potential for case finding in public emergency departments. Ann Emerg Med 1998;32:144-147.
233. Sumartojo EM, Geiter LJ, Miller B, Hale BE. Can physicians treat tuberculosis? Report on a national survey of physician practices. Am J Public Health 1997;87:2008-2011.
234. Rao SN, Mookerjee AL, Obasanjo OO, Chaisson RE. Errors in the treatment of tuberculosis in Baltimore. Chest 2000;117:734-737.
235. LoBue PA, Moser K, Catanzaro A. Management of tuberculosis in San Diego County: a survey of physicians' knowledge, attitudes and practices. Int J Tuberc Lung Dis 2001;5:933-938.
236. Uplekar M, Pathania V, Raviglione M. Private practitioners and public health: weak links in tuberculosis control. Lancet 2001;358:912-916.
237. Ozuah PO, Ozuah TP, Stein RE, Burton W, Mulvihill M. Evaluation of a risk assessment questionnaire used to target tuberculin skin testing in children. JAMA 2001;285:451-453.
238. U.S. Citizenship and Immigration Service. 2002 yearbook of immigration statistics. Washington, DC: U.S. Department of Homeland Security, U.S. Citizenship and Immigration Service, Office of Immigration Statistics;2003. Available from: http://uscis.gov/graphics/shared/aboutus/statistics/ Yearbook2002.pdf.
239. Blum RN, Polish LB, Tapy JM,Catlin BJ, Cohn DL. Results of screening for tuberculosis in foreign-born persons applying for adjustment of immigration status. Chest 1993;103:1670-1674.
240. Saraiya M, Cookson ST, Tribble P, et al. Tuberculosis screening among foreign-born persons applying for permanent US residence. Am J Public Health 2002;92:826-829.
241. Brown TM, Fee E. "Palliatives will no longer do": the deep roots and continuing dynamic of community-oriented primary care.AmJ Public Health 2002;92:1711-1712.
242. Sotir MJ, Parrott P, Metchock B, et al. Tuberculosis in the inner city: impact of a continuing epidemic in the 1990s. Clin Infect Dis 1999;29:1138-1144.
243. Moss AR, Alland D, Telzak E, et al. A city-wide outbreak of a multipledrug-resistant strain of Mycobacterium tuberculosis in New York. Int J Tuberc Lung Dis 1997;1:115-121.
244. Institute of Medicine, Committee on Regulating Occupational Exposure to Tuberculosis. In: Field MJ, editor. Tuberculosis in the workplace. Washington, DC: National Academy Press; 2001.
245. Blumberg HM. tuberculosis infection control. In: Reichman LB, Hershield E, editors. Tuberculosis: a comprehensive international approach. New York: Marcel-Dekker; 2000. pp. 609-643.
246. O'Brien RJ, Nunn PP. The need for new drugs against tuberculosis: obstacles, opportunities, and next steps. Am J Respir Crit Care Med 2001;163:1055-1058.
247. Perkins MD. New diagnostic tools for tuberculosis. Int J Tuberc Lung Dis 2000;4(12, Suppl 2)S182-S188.
248. D'Lugoff MI, Jones W, Kub J, et al. Tuberculosis screening in an atrisk immigrant Hispanic population in Baltimore city: an academic health center/local health department partnership. J Cult Divers 2002;9:79-85.
249. Ashkar BE. Applying advances to the clinic and health care delivery: putting the strategies to work. Int J Tuberc Lung Dis 2000;4(2, Suppl 1)S41-S44.
250. Bellin EY, Fletcher DD, Safyer SM. Association of tuberculosis infection with increased time in or admission to the New York City jail system. JAMA 1993;269:2228-2231.
251. Nardell EA. Tuberculosis in homeless, residential care facilities, prisons, nursing homes, and other close communities. Semin Respir Infect 1989;4:206-215.
252. Hutton MD, Cauthen GM, Bloch AB. Results of a 29-state survey of tuberculosis in nursing homes and correctional facilities. Public Health Rep 1993;108:305-314.
253. White MC, Tulsky JP, Portillo CJ, Menendez E, Cruz E, Goldenson J. Tuberculosis prevalence in an urban jail: 1994 and 1998. Int J Tuberc Lung Dis 2001;5:400-404.
254. Levy MH, Reyes H, Coninx R. Overwhelming consumption in prisons: human rights and tuberculosis control. Health Hum Rights 1999;4:166-191.
255. Lobato MN, Leary LS, Simone PM. Treatment for latent TB in correctional facilities: a challenge for TB elimination. Am J Prev Med 2003;24:249-253.
256. Tulsky JP, White MC, Dawson C, Hoynes TM, Goldenson J, Schecter G. Screening for tuberculosis in jail and clinic follow-up after release. Am J Public Health 1998;88:223-226.
257. White MC, Tulsky JP, Reilly P, McIntosh HW, Hoynes TM, Goldenson J. A clinical trial of a financial incentive to go to the tuberculosis clinic for isoniazid after release from jail. Int J Tuberc Lung Dis 1998;2:506-512.
258. Francis J. Curry National Tuberculosis Center. Tuberculosis infection control plan template for jails. San Francisco, CA: Francis J. Curry National Tuberculosis Center; 2002. Available from: http://www.nationaltbcenter.edu.
259. Broekmans JF, Migliori GB, Rieder HL, et al.;World Health Organization, International Union Against Tuberculosis and Lung Disease, Royal Netherlands Tuberculosis Association Working Group. European framework for tuberculosis control and elimination in countries with a low incidence: recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group. Eur Respir J 2002;19:765-775.
260. Mabey D, Peelin RW, Ustianowsk A, Perkin MD. Tropical infectious diseases: diagnostics for the developing world. Nat Rev Microbiol 2004;2:231-240.
261. Wheeler C, Berkley S. Initial lessons from public-private partnerships in drug and vaccine development. Bull World Health Organ 2001;79:728-734.
262. Gupta R, Kim JY, Espinal MA, et al. Public health: responding to market failures in tuberculosis control. Science 2001;293:1049-1051.
263. Kumaresan J, Smith I, Arnold V, Evans P. The global TB drug facility: innovative global procurement. Int J Tuberc Lung Dis 2004;8:130-138.
264. Yamada S, Caballero J, Matsunaga DS,Agustin G, Magana M. Attitudes regarding tuberculosis in immigrants from the Philippines to the United States. Fam Med 1999;31:477-482.
265. Carey JW, Oxtoby MJ, Nguyen LP, Huynh V, Morgan M, Jeffery M. Tuberculosis beliefs among recent Vietnamese refugees in New York State. Public Health Rep 1997;112:66-72.
266. Bock NN, McGowan JE Jr, Blumberg HM. Few opportunities found for tuberculosis prevention among the urban poor. Int J Tuberc Lung Dis 1998;2:124-129.
267. Miller LG, Asch SM, Yu EI, Knowles L, Gelberg L, Davidson P. A population-based survey of tuberculosis symptoms: how atypical are atypical presentations? Clin Infect Dis 2000;30:293-299.
268. Tattevin P, Casalino E, Fleury L, Egmann G, Ruel M, Bouvet E. The validity of medical history, classic symptoms, and chest radiographs in predicting pulmonary tuberculosis: derivation of a pulmonary tuberculosis prediction model. Chest 1999;115:1248-1253.
269. Catanzaro A, Perry S, Clarridge JE, et al. The role of clinical suspicion in evaluating a new diagnostic test for active tuberculosis: results of a multicenter prospective trial. JAMA 2000;283:639-645.
270. Daley CL, Gotway MB, Jasmer RM. Radiographic manifestations of tuberculosis: a primer for clinicians. San Francisco, CA: Francis J. Curry National Tuberculosis Center; 2003.
271. Cohen R, Muzaffar S, Capellan J, Azar H, Chinikamwala M. The validity of classic symptoms and chest radiographic configuration in predicting pulmonary tuberculosis. Chest 1996;109:420-423.
272. Scott B, Schmid M, Nettleman MD. Early identification and isolation of inpatients at high risk for tuberculosis. Arch Intern Med 1994;154:326-330.
273. Long R. Smear-negative pulmonary tuberculosis in industrialized countries. Chest 2001;120:330-334.
274. Perlman DC, el-Sadr WM, Nelson ET, et al. Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG). Clin Infect Dis 1997;25:242-246.
275. Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C, for the Infectious Diseases Society of America. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003;37:1405-1433.
276. Dasgupta K, Schwartzman K, Marchand R, Tennenbaum TN, Brassard P, Menzies D. Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations. AmJ Respir Crit Care Med 2000;162:2079-2086.
277. Sciortino S, Mohle-Boetani J, Royce SE, Will D, Chin DP. B notifications and the detection of tuberculosis among foreign-born recent arrivals in California. Int J Tuberc Lung Dis 1999;3:778-785.
278. Zuber PL, Binkin NJ, Ignacio AC, et al. Tuberculosis screening for immigrants and refugees: diagnostic outcomes in the state of Hawaii. Am J Respir Crit Care Med 1996;154:151-155.
279. Centers for Disease Control and Prevention. Recommendations for prevention and control of tuberculosis among foreign-born persons: report of the Working Group on Tuberculosis among Foreign-born Persons. MMWR Morb Mortal Wkly Rep 1998;47(RR-16):1-29.
280. Nolan CM, Elarth AM, Barr H, Saeed AM, Risser DR. An outbreak of tuberculosis in a shelter for homeless men: a description of its evolution and control. Am Rev Respir Dis 1991;143:257-261.
281. Kimerling ME, Shakes CF, Carlisle R, Lok KH, Benjamin WH, Dunlap NE. Spot sputum screening: evaluation of an intervention in two homeless shelters. Int J Tuberc Lung Dis 1999;3:613-619.
282. Centers for Disease Control and Prevention. Screening for tuberculosis and tuberculosis infection in populations at high risk: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep 1995;44(RR-11):19-34.
283. Puisis M, Feinglass J, Lidow E, Mansour M. Radiographic screening for tuberculosis in a large urban county jail. Public Health Rep 1996;111:330-334.
284. Jereb J, Etkind SC, Joglar OT,Moore M, Taylor Z. Tuberculosis contact investigations: outcomes in selected areas of the United States, 1999. Int J Tuberc Lung Dis 2003; 7(12, Suppl 3)S384-S390.
285. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis: a general review. Bibl Tuberc 1970;26:28-106.
286. Nivin B, Nicholas P, Gayer M, Frieden TR, Fujiwara PI. A continuing outbreak of multidrug-resistant tuberculosis, with transmission in a hospital nursery. Clin Infect Dis 1998;26:303-307.
287. Hennessey KA, Schulte JM, Valway SE, et al. Using DNA fingerprinting to detect transmission of Mycobacterium tuberculosis among AIDS patients in two health-care facilities in Puerto Rico. South Med J 2000;93:777-782.
288. Garcia-Garcia ML, Jimenez-Corona ME, Ponce-de-Leon A, et al. Mycobacterium tuberculosis drug resistance in a suburban community in southern Mexico. Int J Tuberc Lung Dis 2000;4(12, Suppl 2)S168-S170.
289. Askew GL, Finelli L, Hutton M, et al. Mycobacterium tuberculosis transmission from a pediatrician to patients. Pediatrics 1997;100:19-23.
290. Kenyon TA, Valway SE, Ihle WW, Onorato IM, Castro KG. Transmission of multidrug-resistant Mycobacterium tuberculosis during a long airplane flight. N Engl J Med 1996;334:933-938.
291. Centers for Disease Control and Prevention. Crack cocaine use among persons with tuberculosis: Contra Costa County, California, 1987-1990. MMWR Morb Mortal Wkly Rep 1991;40:485-489.
292. DiStasio AJ II, Trump DH. The investigation of a tuberculosis outbreak in the closed environment of a US Navy ship, 1987. Mil Med 1990;155:347-351.
293. Wells CD, Zuber PL, Nolan CM, Binkin NJ, Goldberg SV. Tuberculosis prevention among foreign-born persons in Seattle-King County, Washington. Am J Respir Crit Care Med 1997;156:573-577.
294. Goldman JM, Teale C, Cundall DB, Pearson SB. Childhood tuberculosis in Leeds, 1982-90: social and ethnic factors and the role of the contact clinic in diagnosis. Thorax 1994;49:184-185.
295. Mehta JB, Bentley S. Prevention of tuberculosis in children: missed opportunities. Am J Prev Med 1992;8:283-286.
296. Rubilar M, Brochwicz-Lewinski MJ, Anderson M, Leitch AG. The outcome of contact procedures for tuberculosis in Edinburgh, Scotland 1982-1991. Respir Med 1995;89:113-120.
297. Topley JM, Maher D, Mbewe LN. Transmission of tuberculosis to contacts of sputum positive adults in Malawi. Arch Dis Child 1996;74:140-143.
298. Centers for Disease Control and Prevention. Multi-drug-resistant tuberculosis: North Carolina. MMWR Morb Mortal Wkly Rep 1987;35:785-787.
299. Etkind SC. Contact tracing in tuberculosis. In: Reichman L, Herschfield E, editors. Tuberculosis: a comprehensive international approach. New York: Marcel Dekker; 1993. pp. 275-289.
300. Ong A, Creasman J, Hopewell PC, et al. A molecular epidemiological assessment of extrapulmonary tuberculosis in San Francisco. Clin Infect Dis 2004;38:25-31.
301. Reichler MR, Bur S, Reves R, et al. Results of testing for human immunodeficiency virus infection among recent contacts of infectious tuberculosis cases in the United States. Int J Tuberc Lung Dis 2003;7(12, Suppl 3):S471-S478.
302. Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing, and referral. MMWR Morb Mortal Wkly Rep 2001;50(RR-19):1-57.
303. Long R, Houston S, Hershfield E, for the Canadian Tuberculosis Committee of Centre for Infectious Disease Prevention and Control, Population and Public Health Branch, Health Canada. Recommendations for screening and prevention of tuberculosis in patients with HIV and for screening for HIV in patients with tuberculosis and their contacts. CMAJ 2003;169:789-791.
304. California Department of Health Services, California Tuberculosis Controllers Association. Joint guidelines for tuberculosis treatment and control in California. Berkeley, CA: California Department of Health Services, California Tuberculosis Controllers Association; 1998. Available from: http://www.ctca.org/publications/guidelines/index.htm.
305. Centers for Disease Control and Prevention. Guidelines for the investigation of contacts to infectious tuberculosis patients. Atlanta, GA: National Tuberculosis Controllers Association, U.S. Department of Health and Human Services. CDC (In press)
306. Veen J. Microepidemics of tuberculosis: the stone-in-the-pond principle. Tuber Lung Dis 1992;73:73-76.
307. Dunlap NE. The use of RFLP as a tool for tuberculosis control: utility or futility? Int J Tuberc Lung Dis 2000;4(12, Suppl 2)S134-S138.
308. Centers for Disease Control and Prevention. Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations: United States, 2001. MMWR Morb Mortal Wkly Rep 2001;50:733-735.
309. American Thoracic Society. Preventive treatment in tuberculosis: a statement by the Committee on Therapy, American Thoracic Society. Am Rev Respir Dis 1965;91:297-298.
310. Mitchell JR, Zimmerman HJ, Ishak KG, et al. Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis. Ann Intern Med 1976;84:181-192.
311. Glassroth J, Bailey WC, Hopewell PC, Schecter G, Harden JW. Why tuberculosis is not prevented. Am Rev Respir Dis 1990;141:1236-1240.
312. Centers for Disease Control and Prevention. Transmission of Mycobacterium tuberculosis associated with failed completion of treatment for latent tuberculosis infection: Chickasaw County, Mississippi, June 1999-March 2002. MMWR Morb Mortal Wkly Rep 2003;52:222-224.
313. Granich RM, Zuber PL, McMillan M, et al. Tuberculosis among foreignborn residents of southern Florida, 1995. Public Health Rep 1998;113:552-556.
314. Liu Z, Shilkret KL, Tranotti J, Freund CG, Finelli L. Distinct trends in tuberculosis morbidity among foreign-born and US-born persons in New Jersey, 1986 through 1995. Am J Public Health 1998;88:1064-7.
315. [Comment in Horsburgh CR Jr. What it takes to control tuberculosis. Am J Public Health 1998;88:1015-1016.]
316. El Sahly HM, Adams GJ, Soini H, Teeter L, Musser JM, Graviss EA. Epidemiologic differences between United States- and foreign-born tuberculosis patients in Houston, Texas. J Infect Dis 2001;183:461-468.
317. Weis SE, Moonan PK, Pogoda JM, et al. Tuberculosis in the foreign-born population of Tarrant County, Texas by immigration status. Am J Respir Crit Care Med 2001;164:953-957.
318. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;320:545-550.
319. Perlman DC, Perkins MP, Solomon N, Kochems L, Des Jarlais DC, Paone D. Tuberculosis screening at a syringe exchange program. Am J Public Health 1997;87:862-863.
320. Nelson KR, Bui H, Samet JH. Screening in special populations: a "case study" of recent Vietnamese immigrants. Am J Med 1997;102:435-440.
321. Pilote L, Tulsky JP, Zolopa AR, Hahn JA, Schecter GF, Moss AR. Tuberculosis prophylaxis in the homeless: a trial to improve adherence to referral. Arch Intern Med 1996;156:161-165.
322. Kohn MR, Arden MR, Vasilakis J, Shenker IR. Directly observed preventive therapy: turning the tide against tuberculosis. Arch Pediatr Adolesc Med 1996;150:727-729.
323. Chang S, Wheeler LS, Farrell KP. Public health impact of targeted tuberculosis screening in public schools. Am J Public Health 2002;92:1942-1945.
324. Geiger HJ. Community-oriented primary care: a path to community development. Am J Public Health 2002;92:1713-1716.
325. Centers for Disease Control and Prevention. Adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection: United States, 2003. MMWR Morb Mortal Wkly Rep 2003;52:735-739.
326. Nolan RJ Jr. Childhood tuberculosis in North Carolina: a study of the opportunities for intervention in the transmission of tuberculosis to children. Am J Public Health 1986;76:26-30.
327. Al-Dossary FS, Ong LT, Correa AG, Starke JR. Treatment of childhood tuberculosis with a six month directly observed regimen of only two weeks of daily therapy. Pediatr Infect Dis J 2002;21:91-97.
328. Centers for Disease Control and Prevention. HIV-related tuberculosis in a transgender network: Baltimore, Maryland, and New York City area, 1998-2000. MMWR Morb Mortal Wkly Rep 2000;49:317-320.
329. Centers for Disease Control and Prevention. Increase in African immigrants and refugees with tuberculosis: Seattle-King County, Washington, 1998-2001. MMWR Morb Mortal Wkly Rep 2002;51:882-883. [Published erratum appears in MMWR Morb Mortal Wkly Rep 51:919.]
330. Centers for Disease Control and Prevention. Trends in tuberculosis morbidity: United States, 1992-2002.MMWR Morb Mortal Wkly Rep 2003;52:217-222.
331. Centers for Disease Control and Prevention. Racial disparities in tuberculosis: selected Southeastern states, 1991-2002. MMWR Morb Mortal Wkly Rep 2004;53:556-559.
332. Centers for Disease Control and Prevention. Trends in tuberculosis: United States, 2004. MMWR Morb Mortal Wkly Rep 2005;54:245-249.
333. Hsu KH. Contact investigation: a practical approach to tuberculosis eradication. Am J Public Health Nations Health 1963;53:1761-1769.
334. Perry S, Starke JR.Adherence to prescribed treatment and public health aspects of tuberculosis in children. Semin Pediatr Infect Dis 1993;4:291-298.
335. Teixeira L, Perkins MD, Johnson JL, et al. Infection and disease among household contacts of patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2001;5:321-328.
336. Schaaf HS,Van RieA,Gie RP, et al. Transmission of multidrug-resistant tuberculosis. Pediatr Infect Dis J 2000;19:695-699.
337. George RH, Gully PR, Gill ON, Innes JA, Bakhshi SS, Connolly M. An outbreak of tuberculosis in a children's hospital. J Hosp Infect 1986;8:129-142.
338. Weinstein JW, Barrett CR, Baltimore RS, Hierholzer WJ Jr. Nosocomial transmission of tuberculosis from a hospital visitor on a pediatrics ward. Pediatr Infect Dis J 1995;14:232-234.
339. Aznar J, Safi H, Romero J, Alejo A, Gracia A, Palomares JC. Nosocomial transmission of tuberculosis infection in pediatrics wards. Pediatr Infect Dis J 1995;14:44-48.
340. Munoz FM,Ong LT, Seavy D, Medina D, Correa A, Starke JR. Tuberculosis among adult visitors of children with suspected tuberculosis and employees at a children's hospital. Infect Control Hosp Epidemiol 2002;23:568-572.
341. American Academy of Pediatrics. Tuberculosis. In: Pickering LK, editor. 2000 red book: report of the Committee on Infectious Diseases, 26th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003. p. 658.
342. Soren K, Saiman L, Irigoyen M, Gomez-Duarte C, Levison MJ, McMahon DJ. Evaluation of household contacts of children with positive tuberculin skin tests. Pediatr Infect Dis J 1999;18:949-955.
343. Driver CR, Cordova IM, Munsiff SS. Targeting tuberculosis testing: the yield of source case investigations for young children with reactive tuberculin skin tests. Public Health Rep 2002;117:366-372.
344. Sullam PM, Slutkin G, Hopewell PC. The benefits of evaluating close associates of child tuberculin reactors from a high prevalence group. Am J Public Health 1986;76:1109-1111.
345. Starke JR. Universal screening for tuberculosis infection: school's out! JAMA 1995;274:652-653.
346. Mohle-Boetani JC, Miller B, Halpern M, et al. School-based screening for tuberculous infection: a cost-benefit analysis. JAMA 1995;274:613-619.
347. Lobato MN, Hopewell PC. Mycobacterium tuberculosis infection after travel to or contact with visitors from countries with a high prevalence of tuberculosis. Am J Respir Crit Care Med 1998;158:1871-1875.
348. Froehlich H, Ackerson LM,Morozumi PA, for the Pediatric Tuberculosis Study Group of Kaiser Pernamente, Northern California. Targeted testing of children for tuberculosis: validation of a risk assessment questionnaire. Pediatrics 2001;107:E54.
349. Saiman L, San Gabriel P, Schulte J, Vargas MP, Kenyon T, Onorato I. Risk factors for latent tuberculosis infection among children in New York City. Pediatrics 2001;107:999-1003.
350. Koppaka VR, Harvey E, Mertz B, Johnson BA. Risk factors associated with tuberculin skin test positivity among university students and the use of such factors in the development of a targeted screening program. Clin Infect Dis 2003;36:599-607.
351. Binkin NJ, Zuber PL, Wells CD, Tipple MA, Castro KG. Overseas screening for tuberculosis in immigrants and refugees to the United States: current status. Clin Infect Dis 1996;23:1226-1232.
352. U.S. Department of Homeland Security. Yearbook of Immigration Statistics, 2003. Washington, DC: U.S. Government Printing Office; 2004. Available from: http://uscis.gov/graphics/shared/statistics/yearbook/index.htm.
353. Enarson D, Ashley MJ, Grzybowski S. Tuberculosis in immigrants to Canada: a study of present-day patterns in relation to immigration trends and birthplace. Am Rev Respir Dis 1979;119:11-18.
354. Nolan CM, Elarth AM. Tuberculosis in a cohort of southeast Asian refugees: a five-year surveillance study. Am Rev Respir Dis 1988;137:805-809.
355. World Health Organization. Global tuberculosis control: surveillance, planning, financing. Geneva, Switzerland: World Health Organization; 2004. Available from: http://www.who.int/tb/publications/global_report/2004/en.
356. Sharnprapai S, Miller AC, Suruki R, et al. Genotyping analyses of tuberculosis cases in US- and foreign-born Massachusetts residents. Emerg Infect Dis 2002;8:1239-1245.
357. Borgdorff MW, Behr MA, Nagelkerke NJ, Hopewell PC, Small PM. Transmission of tuberculosis in San Francisco and its association with immigration and ethnicity. Int J Tuberc Lung Dis 2000;4:287-294.
358. U.S. Immigration and Naturalization Service. Estimates of the unauthorized immigrant population residing in the United States: 1990 to 2000. Washington, DC: U.S. Immigration and Naturalization Service, Office of Policy and Planning; 2003. Available from: http://uscis.gov/graphics/shared/aboutus/ statistics/Ill_Report_1211.pdf.
359. Centers for Disease Control and Prevention. Technical instructions for panel physicians. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2002. Available from: http://www.cdc.gov/ncidod/dq/panel.htm.
360. Centers for Disease Control and Prevention. CDC's response to ending neglect: the elimination of tuberculosis in the United States. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2002. Available from: http://www. cdc.gov/nchstp/tb/pubs/iom/ iomresponse/iomresponse.pdf.
361. Wells CD, Ocana M, Moser K, Bergmire-Sweat D, Mohle-Boetani JC, Binkin NJ. A study of tuberculosis among foreign-born Hispanic persons in the U.S. states bordering Mexico. Am J Respir Crit Care Med 1999;159:834-837.
362. Centers for Disease Control and Prevention. Preventing and controlling tuberculosis along the US-Mexico border.MMWRMorb Mortal Wkly Rep 2001;50(RR-1):1-27.
363. DeRiemer K, Chin DP, Schecter GF, Reingold AL. Tuberculosis among immigrants and refugees. Arch Intern Med 1998;158:753-760.
364. Zuber PL, Knowles LS, Binkin NJ, Tipple MA, Davidson PT. Tuberculosis among foreign-born persons in Los Angeles County, 1992-1994. Tuber Lung Dis 1996;77:524-530.
365. Catlos EK, Cantwell MF, Bhatia G, Gedin S, Lewis J, Mohle-Boetani JC. Public health interventions to encourage TB class A/B1/B2 immigrants to present for TB screening. Am J Respir Crit Care Med 1998;158:1037-1041.
366. Weis SE, Burgess G. Tuberculosis control in a border state: treatment of the foreign-born. Infect Dis Clin North Am 2002;16:59-71.
367. White MC, Gournis E, Kawamura M, Menendez E, Tulsky JP. Effect of directly observed preventive therapy for latent tuberculosis infection in San Francisco. Int J Tuberc Lung Dis 2003;7:30-35.
368. Hennessey KA, Schulte JM, Cook L, Collins M, Onorato IM, Valway SE. Tuberculin skin test screening practices among US colleges and universities. JAMA 1998;280:2008-2012.
369. Whalen CC, Nsubuga P, Okwera A, et al. Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda. AIDS 2000;14:1219-1228.
370. Havlir DV, Barnes PF. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1999;340:367-373.
371. Bucher HC, Griffith LE, Guyatt GH, et al. Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. AIDS 1999;13:501-507.
372. Markowitz N, Hansen NI, Hopewell PC, et al. Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary Complications of HIV Infection Study Group. Ann Intern Med 1997;126:123-132.
373. Pape JW, Jean SS, Ho JL, Hafner A, JohnsonWDJr. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993;342:268-272.
374. Mukadi YD, Maher D, Harries A. Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS 2001;15:143-152.
375. Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS 2002 report on the global HIV/AIDS epidemic. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS; 2002.
376. Mocroft A, Vella S, Benfield TL, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 1998;352:1725-1730.
377. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodefi-ciency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-860.
378. Detels R, Munoz A, McFarlane G, et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. JAMA 1998;280:1497-1503.
379. Jones JL, Hanson DL, Dworkin MS, et al. Surveillance for AIDSdefining opportunistic illnesses, 1992-1997. In: CDC Surveillance Summaries, April 16, 1999. MMWR Morb Mortal Wkly Rep 1999;48(SS-2):1-22.
380. Barnes PF, Bloch AB, Davidson PT, Snider DE Jr. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991;324:1644-1650.
381. Shafer RW, Edlin BR. Tuberculosis in patients infected with human immunodeficiency virus: perspective on the past decade. Clin Infect Dis 1996;22:683-704.
382. Selwyn PA, Pumerantz AS, Durante A, et al. Clinical predictors of Pneumocystis carinii pneumonia, bacterial pneumonia and tuberculosis in HIV-infected patients. AIDS 1998;12:885-893.
383. Burman WJ, Jones BE. Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy. Am J Respir Crit Care Med 2001;164:7-12.
384. Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 1998;158:157-161.
385. Alwood K, Keruly J, Moore-Rice K, Stanton DL, Chaulk CP, Chaisson RE. Effectiveness of supervised, intermittent therapy for tuberculosis in HIV-infected patients. AIDS 1994;8:1103-1108.
386. Espinal MA, Perez EN, Baez J, et al. Infectiousness of Mycobacterium tuberculosis in HIV-1-infected patients with tuberculosis: a prospective study. Lancet 2000;355:275-280.
387. Carvalho AC,DeRiemer K, Nunes ZB,Martins M, Comelli M, Marinoni A. Transmission of Mycobacterium tuberculosis to contacts of HIVinfected tuberculosis patients. Am J Respir Crit Care Med 2001;164:2166-2171.
388. Cruciani M, Malena M, Bosco O, Gatti G, Serpelloni G. The impact of human immunodeficiency virus type 1 on infectiousness of tuberculosis: a meta-analysis. Clin Infect Dis 2001;33:1922-1930.
389. Centers for Disease Control and Prevention. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. MMWR Morb Mortal Wkly Rep 1998;47(RR-20):1-58.
390. Gordin F, Chaisson RE, Matts JP, et al. Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the CDC Study Group. JAMA 2000;283:1445-1450.
391. Link B, Phelan J, Bresnahan M, Stueve A, Moore R, Susser E. Lifetime and five-year prevalence of homelessness in the United States: new evidence on an old debate. Am J Orthopsychiatry 1995;65:347-354.
392. Kearns AM, Barrett A, Marshall C, et al. Epidemiology and molecular typing of an outbreak of tuberculosis in a hostel for homeless men. J Clin Pathol 2000;53:122-124.
393. McElroy PD, Southwick KL, Fortenberry ER, et al. Outbreak of tuberculosis among homeless persons coinfected with human immunodeficiency virus. Clin Infect Dis 2003;36:1305-1312.
394. Barnes PF. Tuberculosis among the inner city poor. Int J Tuberc Lung Dis 1998;2(9, Suppl 1)S41-S45.
395. Brewer TF, Heymann SJ, Krumplitsch SM, Wilson ME, Colditz GA, Fineberg HV. Strategies to decrease tuberculosis in US homeless populations: a computer simulation model. JAMA 2001;286:834-842.
396. Burman WJ, Cohn DL, Rietmeijer CA, Judson FN, Sbarbaro JA, Reves RR. Noncompliance with directly observed therapy for tuberculosis: epidemiology and effect on the outcome of treatment. Chest 1997;111:1168-1173.
397. Southern A, Premaratne N, English M, Balazs J, O'Sullivan D. Tuberculosis among homeless people in London: an effective model of screening and treatment. Int J Tuberc Lung Dis 1999;3:1001-1008.
398. Rendleman NJ. Mandated tuberculosis screening in a community of homeless people. Am J Prev Med 1999;17:108-113.
399. Marks SM, Taylor Z, Burrows NR, Qayad MG, Miller B. Hospitalization of homeless persons with tuberculosis in the United States. Am J Public Health 2000;90:435-438.
400. LoBue PA, Cass R, Lobo D, Moser K, Catanzaro A. Development of housing programs to aid in the treatment of tuberculosis in homeless individuals: a pilot study. Chest 1999;115:218-223.
401. Diez E, Claveria J, Serra T, et al. Evaluation of a social health intervention among homeless tuberculosis patients. Tuber Lung Dis 1996;77:420-424.
402. Singleton L, Turner M, Haskal R, Etkind S, Tricarico M, Nardell E. Long-term hospitalization for tuberculosis control: experience with a medical-psychosocial inpatient unit. JAMA 1997;278:838-842.
403. Tulsky JP, Pilote L, Hahn JA, et al. Adherence to isoniazid prophylaxis in the homeless: a randomized controlled trial. Arch Intern Med 2000;160:697-702.
404. Hammett TM, Harmon MP,Rhodes W. The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. Am J Public Health 2002;92:1789-1794.
405. Steenland K, Levine AJ, Sieber K, Schulte P, Aziz D. Incidence of tuberculosis infection among New York State prison employees. Am J Public Health 1997;87:2012-2014.
406. Valway SE, Richards SB, Kovacovich J, Greifinger RB, Crawford JT, Dooley SW. Outbreak of multi-drug-resistant tuberculosis in a New York State prison, 1991. Am J Epidemiol 1994;140:113-122.
407. Centers for Disease Control and Prevention. Probable transmission of multidrug-resistant tuberculosis in a correctional facility: California. MMWR Morb Mortal Wkly Rep 1993;42:48-51.
408. Pelletier AR, DiFerdinando GT Jr, Greenberg AJ, et al. Tuberculosis in a correctional facility. Arch Intern Med 1993;153:2692-2695.
409. Valway SE, Greifinger RB, Papania M, et al. Multidrug-resistant tuberculosis in the New York State prison system, 1990-1991. J Infect Dis 1994;170:151-156.
410. Centers for Disease Control and Prevention. Outbreak of multidrug-resistant tuberculosis at a hospital: New York City, 1991. MMWR Morb Mortal Wkly Rep 1993;42:427-434.
411. Bock NN, Reeves M, LaMarre M, DeVoeB. Tuberculosis case detection in a state prison system. Public Health Rep 1998;113:359-364.
412. Anderson KM, Keith EP, Norsted SW. Tuberculosis screening in Washington State male correctional facilities. Chest 1986;89:817-821.
413. Jones TF, Schaffner W. Miniature chest radiograph screening for tuberculosis in jails: a cost-effectiveness analysis. Am J Respir Crit Care Med 2001;164:77-81.
414. Klopf LC. Tuberculosis control in the New York State Department of Correctional Services: a case management approach. Am J Infect Control 1998;26:534-537.
415. Johnsen C. Tuberculosis contact investigation: two years of experience in New York City correctional facilities. Am J Infect Control 1993;21:1-4.
416. Kendig N. Tuberculosis control in prisons. Int J Tuberc Lung Dis 1998;2(9, Suppl 1)S57-S63.
417. Alcabes P, Vossenas P, Cohen R, Braslow C, Michaels D, Zoloth S. Compliance with isoniazid prophylaxis in jail. Am Rev Respir Dis 1989;140:1194-1197.
418. Centers for Disease Control and Prevention. Tuberculosis prevention in drug-treatment centers and correctional facilities: selected US sites, 1990-1991. MMWR Morb Mortal Wkly Rep 1993;42:210-213.
419. Reichard AA, Lobato MN, Roberts CA, Bazerman LB, Hammett TM. Assessment of tuberculosis screening and management practices of large jail systems. Public Health Rep 2003;118:500-507.
420. Bock NN, Rogers T, Tapia JR, Herron GD, DeVoe B, Geiter LJ. Acceptability of short-course rifampin and pyrazinamide treatment of latent tuberculosis infection among jail inmates. Chest 2001;119:833-837.
421. MacIntyre CR, Kendig N, Kummer L, Birago S, Graham NM. Impact of tuberculosis control measures and crowding on the incidence of tuberculous infection in Maryland prisons. Clin Infect Dis 1997;24:1060-1067.
422. Zaza S, Blumberg HM, Beck-Sague C, et al. Nosocomial transmission of Mycobacterium tuberculosis: role of health care workers in outbreak propagation. J Infect Dis 1995;172:1542-1549.
423. McGowan JE Jr. Nosocomial tuberculosis: new progress in control and prevention. Clin Infect Dis 1995;21:489-505.
424. Wenger PN, Otten J, Breeden A, Orfas D, Beck-Sague CM, Jarvis WR. Control of nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis among healthcare workers and HIV-infected patients. Lancet 1995;345:235-240.
425. Maloney SA, Pearson ML, Gordon MT, Del Castillo R, Boyle JF, Jarvis WR. Efficacy of control measures in preventing nosocomial transmission of multidrug-resistant tuberculosis to patients and health care workers. Ann Intern Med 1995;122:90-95.
426. Jarvis WR. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. Am J Infect Control 1995;23:146-151.
427. Kenyon TA, Ridzon R, Luskin-Hawk R, et al. A nosocomial outbreak of multidrug-resistant tuberculosis. Ann Intern Med 1997;127:32-36.
428. Blumberg HM, White N, Parrott P, Gordon W, Hunter M, Ray S. Falsepositive tuberculin skin test results among health care workers. JAMA 2000;283:2793.
429. Barrett-Connor E. The epidemiology of tuberculosis in physicians. JAMA 1979;241:33-38.
430. Fraser VJ, Kilo CM, Bailey TC, Medoff G, Dunagan WC. Screening of physicians for tuberculosis. Infect Control Hosp Epidemiol 1994;15:95-100.
431. Geiseler PJ, Nelson KE, Crispen RG. Tuberculosis in physicians: compliance with preventive measures. Am Rev Respir Dis 1987;135:3-9.
432. Camins BC, Bock N, Watkins DL, Blumberg HM. Acceptance of isoniazid preventive therapy by health care workers after tuberculin skin test conversion. JAMA 1996;275:1013-1015.
433. Shukla SJ, Warren DK, Woeltje KF, Gruber CA, Fraser VJ. Factors associated with the treatment of latent tuberculosis infection among health-care workers at a midwestern teaching hospital. Chest 2002;122:1609-1614.
434. Centers for Disease Control and Prevention. Prevention and control of tuberculosis in facilities providing long-term care to the elderly: recommendations of the Advisory Committee for Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep 1990;39(RR-10):7-20.
435. Ijaz K, Dillaha JA, Yang Z, Cave MD, Bates JH.Unrecognized tuberculosis in a nursing home causing death with spread of tuberculosis to the community. J Am Geriatr Soc 2002;50:1213-1218.
436. Stead WW. Tuberculosis among elderly persons, as observed among nursing home residents. Int J Tuberc Lung Dis 1998;2(9, Suppl 1)S64-S70.
437. Ijaz K, Yang Z, Templeton G, Stead WW, Bates JH, Cave MD. Persistence of a strain of Mycobacterium tuberculosis in a prison system. Int J Tuberc Lung Dis 2004;8:994-1000.
438. Nardell EA. Environmental infection control of tuberculosis. Semin Respir Infect 2003;18:307-319.
439. Francis J. Curry National Tuberculosis Center, Institutional Consultation Services, California Department of Health Services. Tuberculosis in homeless shelters: reducing the risk through ventilation, filters, and UV. San Francisco, CA: Francis J. Curry National Tuberculosis Center; 2000. Available from: http://www.nationaltbcenter.edu/catalogue/downloads/tbhomelessshelters.pdf.
440. Klovdahl AS, Graviss EA, Yaganehdoost A, et al. Networks and tuberculosis: an undetected community outbreak involving public places. Soc Sci Med 2001;52:681-694.
441. Ginsberg AM. A proposed national strategy for tuberculosis vaccine development. Clin Infect Dis 2000;30:S233-S242.
442. Centers for Disease Control and Prevention. Framework for evaluating public health surveillance systems for early detection of outbreaks: recommendations from the CDC Working Group. MMWR Morb Mortal Wkly Rep 2004;53(RR-5):1-11.